United States · FDA National Drug Code directory

VALSARTAN AND HYDROCHLOROTHIAZIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43547-312_2d03a607-2ffd-4df1-8c94-bec2b786709c
Product NDC
43547-312
Form
TABLET, FILM COATED
Composition / generic term
valsartan and hydrochlorothiazide
Labeler
Solco Healthcare US, LLC
Marketing category
ANDA
Marketing start / end (source format)
20151031
Source listing expiry
20271231

Source-listed ingredients

  • VALSARTAN — 160 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (43547-312-03) · 43547-312-03
  • 90 TABLET, FILM COATED in 1 BOTTLE (43547-312-09) · 43547-312-09
  • 500 TABLET, FILM COATED in 1 BOTTLE (43547-312-50) · 43547-312-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
VALSARTAN AND HYDROCHLOROTHIAZIDE — United States | Molindra Medicines